SWARMS 24-hour volatility at 41.6%: Launchpad activity and surge in trading volume drive a 28% increase
Bitget Pulse2026/04/17 00:02Volatility Brief
SWARMS rebounded from a low of $0.01353 to a high of $0.01856 in the past 24 hours, currently priced at $0.01823, with a 24-hour increase of 27.59% and an amplitude of 41.6%. The 24-hour trading volume has significantly expanded to approximately $5.63 million, and the market capitalization is about $18.23 million.
Analysis of Abnormal Movements
- Swarms Launchpad's revenue exceeded $1 million in the past 24 hours, ranking in the top ten. The Frenzy Mode feature attracts builders to participate, increasing earnings for creators' fees.
- The project team held a Live Space on April 16, announcing Launchpad updates and new features, such as top-tier agent market cap display, enhancing platform exposure.
- Trading signals appeared frequently, with several traders issuing long recommendations for $SWARMS. Entry prices are $0.0136-$0.017, with a target of $0.018-$0.023.
Market Perspective and Outlook
Community sentiment remains predominantly bullish, with CoinGecko indicating 75% positive sentiment; most traders issue long-term signals, viewing levels above $0.016 as bullish. However, some users on X accuse Launchpad-associated projects of crashing and suspect manipulation, urging caution. The short-term momentum of Launchpad may continue, but meme coin volatility risk remains high—it's recommended to monitor trading volume and the Solana ecosystem.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
